Bluejay Diagnostics BJDX
NASDAQ BJDX
$0.84 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bluejay Diagnostics (BJDX) Asset Writedowns and Impairment (2022 - 2026)

Updated

Bluejay Diagnostics (BJDX) recorded Asset Writedowns and Impairment of $26,706 in Q1 2026, up 355.1% from the prior quarter.

Analysis

Bluejay Diagnostics (BJDX) Asset Writedowns and Impairment (2022 - 2026) Analysis & Trends

For FY2025, Bluejay Diagnostics reported Asset Writedowns and Impairment of $42,937.

  • Annual Asset Writedowns and Impairment has a three-year compound annual growth rate of -43.4% (FY2022 to FY2025).
  • Across earlier years, Asset Writedowns and Impairment came in at $3,411 in FY2024 (+90.9%), $1,787 in FY2023 (-99.2%) and $237,309 in FY2022.
  • Quarterly Asset Writedowns and Impairment has ranged from $2,486 in Q4 2024 to $36,574 in Q3 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Bluejay Diagnostics 1.67 Mn 1.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 26,706.00
Dec 31, 2025 5,868.00
Sep 30, 2025 36,574.00
Dec 31, 2024 2,486.00
Dec 31, 2022 27,192.00
API Access

Bluejay Diagnostics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=BJDX&period=max&api_key=YOUR_API_KEY